Federated Hermes, Inc. Charles River Laboratories International, Inc. Transaction History
Federated Hermes, Inc.
- $43.9 Billion
- Q1 2025
A detailed history of Federated Hermes, Inc. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Federated Hermes, Inc. holds 225 shares of CRL stock, worth $40,272. This represents 0.0% of its overall portfolio holdings.
Number of Shares
225
Previous 2,397
90.61%
Holding current value
$40,272
Previous $442,000
92.53%
% of portfolio
0.0%
Previous 0.0%
Shares
31 transactions
Others Institutions Holding CRL
# of Institutions
625Shares Held
55MCall Options Held
722KPut Options Held
847K-
Vanguard Group Inc Valley Forge, PA6.11MShares$1.09 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$911 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA4.29MShares$767 Million0.13% of portfolio
-
Ubs Group Ag2.39MShares$428 Million0.07% of portfolio
-
Allspring Global Investments Holdings, LLC2.29MShares$410 Million0.63% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $9.1B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...